Olle Ringdén, MD, PhD
Karolinska Institutet
5
5
1
N/A
0
0
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (5)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Arnon Nagler, MD
Chaim Sheba Medical Center
Shared therapeutic areas:
Michael Y Shapira, MD
Hadassah Medical Organization
Shared therapeutic areas:
Zhaoping Li, MD, PhD
University of California, Los Angeles
Shared therapeutic areas:
Joel Neutel, MD
Orange County Research Center
Shared therapeutic areas:
Meral Boşnak Güçlü, PhD
Gazi University
Shared therapeutic areas:
Areej El-Jawahri, MD
Massachusetts General Hospital
Shared therapeutic areas:
Ryotaro Nakamura
City of Hope Medical Center
Shared therapeutic areas:
Project Leader, Development Planning
Ono Pharmaceutical Co., Ltd.
Shared therapeutic areas:
William I. Bensinger, MD
Fred Hutchinson Cancer Center
Shared therapeutic areas:
David C Nieman, DrPH
Appalachian State Univ
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (5)
Showing 5 of 5 trials
A Phase 2 Study Using Placenta Derived Decidual Stromal Cells for Graft Versus Host Disease
Decidual Stromal Cells as Treatment for Acute Graft Versus Host Disease, a Phase 1-2 Study
A Pilot Study Using Placenta Derived Decidual Stromal Cells for Hemorrhagic Cystitis
A Double Blind Randomized Study Using Placenta Derived Decidual Stromal Cells for Hemorrhagic Cystitis
A Pilot Study Using Placenta Derived Decidual Stromal Cells for Toxicity and Inflammation With Special Focus to the Allogeneic Hematopoietic Cell Transplantation Setting
All 5 trials loaded